Your browser doesn't support javascript.
loading
The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
Whitfield, Michael G; Warren, Robin M; Mathys, Vanessa; Scott, Lesley; De Vos, Elise; Stevens, Wendy; Streicher, Elizabeth M; Groenen, Guido; Sirgel, Frederick A; Van Rie, Annelies.
Afiliação
  • Whitfield MG; South Africa Medical Research Council (SAMRC) Centre for Tuberculosis Research DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Stellenbosch University, South Africa.
  • Warren RM; South Africa Medical Research Council (SAMRC) Centre for Tuberculosis Research DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Stellenbosch University, South Africa.
  • Mathys V; Bacterial Diseases Service, Operational Direction Communicable and Infectious Diseases, Scientific Institute of Public Health (WIV-ISP), Brussels, Belgium.
  • Scott L; National Health Laboratory Services, South Africa.
  • De Vos E; Department of Molecular Medicine and Haematology, University of Witwatersrand, School of Pathology Faculty of Health Science, Johannesburg, South Africa.
  • Stevens W; Global Health Institute, Epidemiology and Social Medicine Faculty of Medicine, University of Antwerp, Antwerp, Belgium.
  • Streicher EM; National Health Laboratory Services, South Africa.
  • Groenen G; Department of Molecular Medicine and Haematology, University of Witwatersrand, School of Pathology Faculty of Health Science, Johannesburg, South Africa.
  • Sirgel FA; South Africa Medical Research Council (SAMRC) Centre for Tuberculosis Research DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Stellenbosch University, South Africa.
  • Van Rie A; Belgian Lung and Tuberculosis Association, Brussels, Belgium.
J Antimicrob Chemother ; 73(10): 2667-2674, 2018 10 01.
Article em En | MEDLINE | ID: mdl-29982641
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rifampina / Tuberculose Resistente a Múltiplos Medicamentos / Rifabutina / Antibióticos Antituberculose / Mycobacterium tuberculosis Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Humans País/Região como assunto: Africa / Europa Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2018 Tipo de documento: Article País de afiliação: África do Sul País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rifampina / Tuberculose Resistente a Múltiplos Medicamentos / Rifabutina / Antibióticos Antituberculose / Mycobacterium tuberculosis Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Humans País/Região como assunto: Africa / Europa Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2018 Tipo de documento: Article País de afiliação: África do Sul País de publicação: Reino Unido